GB Meka
Stocks to watch

ABBV

Compare

AbbVie Inc · Healthcare

$263.76
▲ 0.2%Close 2026-09-30

Live intraday price

Compare with our price levels

T2279.65
T1269.39
E1257.48
E3241.34
SL236.21

Close 2026-09-30: $263.76 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Waiting• Neutral

Not in the buy zone yet — needs to drop 2.4% · 1 whale recently bought

1 month
▲ 2.9%
3 months
▲ 5.8%
1 year
▲ 21.9%
Analyst target
$278.56 +5.6%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$257.48 -2.4%
E2$246.77 -6.4%
E3$241.34 -8.5%
Targets
T1$269.39 2.1%
T2$279.65 6.0%
T3$289.90 9.9%
Stop-loss
SL$236.21 -10.4%
Whale cost ~$216.75 -17.8%

Risk : reward 1 : 2.5Moves ~$5.13 a day

⚖️ Positives and risks

✓ Positives (3)
  • ●เซียนซื้อใหม่/ซื้อเพิ่มไตรมาสล่าสุด 1 ราย
  • ●แนวโน้มระยะยาวเป็นขาขึ้น (เหนือ MA200 และ MA200 ชี้ขึ้น)
  • ●นักวิเคราะห์ส่วนใหญ่แนะนำ Buy
! Risks (2)
  • ●เซียนขายออก/ลดสัดส่วน 3 ราย: Bridgewater (ลด), Mario Gabelli (ลด), Bill Nygren (ลด)
  • ●MACD เพิ่งตัดลง (โมเมนตัมอ่อนลง)

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

📊 Past earnings and price reaction

Actual EPS vs. analyst estimates · the price move on the first trading day after the report and over the next 20 trading days

Post-earnings, all stocks
2026-07-31In line +1%

Actual EPS $3.65 · est. $3.61 · Before open

▼ 2.5%

Day 1

+1.8%

Next 20 days

2026-04-29In line -1%

Actual EPS $2.65 · est. $2.67 · Before open

▲ 3.1%

Day 1

+7.2%

Next 20 days

2026-02-04In line +2%

Actual EPS $2.71 · est. $2.65 · Before open

▼ 3.8%

Day 1

+7.0%

Next 20 days

2025-10-31In line +4%

Actual EPS $1.86 · est. $1.78 · Before open

▼ 4.5%

Day 1

+3.2%

Next 20 days

2025-07-31In line +2%

Actual EPS $2.97 · est. $2.91 · Before open

▼ 0.2%

Day 1

+10.0%

Next 20 days

2025-04-25In line +3%

Actual EPS $2.46 · est. $2.40 · Before open

▲ 3.2%

Day 1

-1.5%

Next 20 days

2025-01-31In line +2%

Actual EPS $2.16 · est. $2.12 · Before open

▲ 4.7%

Day 1

+15.0%

Next 20 days

2024-10-30In line +3%

Actual EPS $3.00 · est. $2.92 · Before open

▲ 6.4%

Day 1

-9.1%

Next 20 days

Listen to the earnings call or read the full report on ABBV's investor relations page ↗ · Earnings data from Yahoo Finance

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

🎬 Videos about ABBV

From the analyst YouTube channels we follow — opinions belong to each channel, not recommendations from this site

All videos

📰 Latest news

All news

No news yet (we only fetch news for stocks with a signal or a high whale score)

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$472.6B
Next earnings2026-10-29
P/E (price to earnings)75.3
Forward P/E (on expected earnings)16.4
Revenue growth (YoY)+10.2%
Earnings growth (YoY)+290.4%
Net profit margin+9.8%
ROE-
Debt to equity (D/E)-
Dividend yield2.62%
Analyst targets (high / low)$328.00 / $200.00
Number of analysts27
Trend and technical indicators
Trend short / mid / longUptrend ↗ · Uptrend ↗ · Uptrend ↗
RSI56
MA50 / MA200$257.64 / $229.08
Distance from MA200+15.1%
MACDJust crossed down
1-year high / low$269.39 / $189.40
vs. S&P 500 (6 months)+4.4%
Volume vs. average0.14×